StonvexLoading…
StonvexStonvexStonvexCore line items from FITB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 | Annual 2023 2023-12-31 |
|---|---|---|---|---|
Revenue | $467.00M | $306.00M | $151.00M | $577.00M |
Operating Income | $2.15B | $1.42B | $658.00M | $2.99B |
Net Income | $1.69B | $1.12B | $520.00M | $2.35B |
EPS (Diluted) | $2.28 | $1.51 | $0.70 | $3.22 |
Total Assets | $214.32B | $213.26B | $214.51B | $214.57B |
Total Liabilities | $193.53B | $194.04B | $195.49B | $195.40B |
Cash & Equivalents | $3.21B | $2.84B | $2.80B | $3.14B |
Free Cash Flow OCF − CapEx | $2.66B | $909.00M | $321.00M | $4.02B |
Shares Outstanding | 676.27M | 680.79M | 683.81M | 681.12M |